| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:2986-2994.)
© 2008 American Heart Association, Inc.
Molecular Cardiology |
From the Translational Medicine Branch (F.M.G., P.S.V., L.H., A.H.A., R.O.C., A.E.A.) and Pulmonary-Vascular Medicine Branch (S.S., L.A.R., M.T.G.), National Heart, Lung, and Blood Institute; Critical Care Medicine Department (S.S., L.A.R., M.T.G.) and Pharmacy Department (Y.Y.H.), Clinical Center, National Institutes of Health; and Howard Hughes Medical Institute, National Institutes of Health Research Scholars Program (F.M.G.), Bethesda, Md.
Correspondence to Andrew Arai, MD, National Heart, Lung, and Blood Institute, National Institutes of Health, Bldg 10, Room B1D416, MSC 1061, 10 Center Dr, Bethesda, MD 20892-1061. E-mail araia{at}nih.gov
Received October 27, 2007; accepted March 12, 2008.
Background— Accumulating evidence suggests that the ubiquitous anion nitrite (NO2–) is a physiological signaling molecule, with roles in intravascular endocrine nitric oxide transport, hypoxic vasodilation, signaling, and cytoprotection. Thus, nitrite could enhance the efficacy of reperfusion therapy for acute myocardial infarction. The specific aims of this study were (1) to assess the efficacy of nitrite in reducing necrosis and apoptosis in canine myocardial infarction and (2) to determine the relative role of nitrite versus chemical intermediates, such as S-nitrosothiols.
Methods and Results— We evaluated infarct size, microvascular perfusion, and left ventricular function by histopathology, microspheres, and magnetic resonance imaging in 27 canines subjected to 120 minutes of coronary artery occlusion. This was a blinded, prospective study comparing a saline control group (n=9) with intravenous nitrite during the last 60 minutes of ischemia (n=9) and during the last 5 minutes of ischemia (n=9). In saline-treated control animals, 70±10% of the area at risk was infarcted compared with 23±5% in animals treated with a 60-minute nitrite infusion. Remarkably, a nitrite infusion in the last 5 minutes of ischemia also limited the extent of infarction (36±8% of area at risk). Nitrite improved microvascular perfusion, reduced apoptosis, and improved contractile function. S-Nitrosothiol and iron-nitrosyl-protein adducts did not accumulate in the 5-minute nitrite infusion, suggesting that nitrite is the bioactive intravascular nitric oxide species accounting for cardioprotection.
Conclusions— Nitrite has significant potential as adjunctive therapy to enhance the efficacy of reperfusion therapy for acute myocardial infarction.
This article has been cited by other articles:
![]() |
C. Jung, A. T. Gonon, P.-O. Sjoquist, J. O. Lundberg, and J. Pernow Arginase inhibition mediates cardioprotection during ischaemia-reperfusion Cardiovasc Res, September 18, 2009; (2009) cvp303v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dezfulian, S. Shiva, A. Alekseyenko, A. Pendyal, D.G. Beiser, J. P. Munasinghe, S. A. Anderson, C. F. Chesley, T.L. Vanden Hoek, and M. T. Gladwin Nitrite Therapy After Cardiac Arrest Reduces Reactive Oxygen Species Generation, Improves Cardiac and Neurological Function, and Enhances Survival via Reversible Inhibition of Mitochondrial Complex I Circulation, September 8, 2009; 120(10): 897 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Calvert and D. J. Lefer Myocardial protection by nitrite Cardiovasc Res, July 15, 2009; 83(2): 195 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G Hord, Y. Tang, and N. S Bryan Food sources of nitrates and nitrites: the physiologic context for potential health benefits Am. J. Clinical Nutrition, July 1, 2009; 90(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tsikas and R. Rossi Letter by Tsikas and Rossi Regarding Article, "Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial Infarction" Circulation, May 19, 2009; 119(19): e531 - e531. [Full Text] [PDF] |
||||
![]() |
D. H. Perlman, S. M. Bauer, H. Ashrafian, N. S. Bryan, M. F. Garcia-Saura, C. C. Lim, B. O. Fernandez, G. Infusini, M. E. McComb, C. E. Costello, et al. Mechanistic Insights Into Nitrite-Induced Cardioprotection Using an Integrated Metabolomic/Proteomic Approach Circ. Res., March 27, 2009; 104(6): 796 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Kato and M. T. Gladwin Evolution of Novel Small-Molecule Therapeutics Targeting Sickle Cell Vasculopathy JAMA, December 10, 2008; 300(22): 2638 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Feelisch, B. O. Fernandez, N. S. Bryan, M. F. Garcia-Saura, S. Bauer, D. R. Whitlock, P. C. Ford, D. R. Janero, J. Rodriguez, and H. Ashrafian Tissue Processing of Nitrite in Hypoxia: AN INTRICATE INTERPLAY OF NITRIC OXIDE-GENERATING AND -SCAVENGING SYSTEMS J. Biol. Chem., December 5, 2008; 283(49): 33927 - 33934. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |